MustGrow Announces First Quarter 2026 Financial Results

About this update from Mustgrow Biologics Corp.

Investor Webcast: Friday, May 29th at 4:00pm ET / 1:00pm PTRegister/View Here: https://us02web.zoom.us/webinar/register/7717781882447/WN_m6cQAgeQSD6hjP6JeVpfbw Please join/register at least 5 minutes prior to the call. Email questions before 2:00pm ET to [email protected], which will be addressed during the Q&A portion of the webcast. Saskatoon, Saskatchewan--(Newsfile Corp. - May 28, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce its operating and financial results for the three months ended March 31, 2026. For complete details, please refer to the condensed interim financial statements for the three months ended March 31, 2026, and associated management's discussion and analysis, available on the Company's profile at SEDAR+: www.sedarplus.ca or on the Company's website at: www.mustgrow.ca. Key Highlights for Q1-2026: "During the first quarter, our TerraSante™ contract manufacturers were increasing production capacity to accommodate our forward-looking product requirements, resulting in short-term manufacturing disruptions as production expanded from 'batch' production to 'continuous' lines dedicated to produce at higher volume rates," commented Corey Giasson, President and CEO of MustGrow. "These manufacturing disruptions have carried over to the second quarter, however, despite these disruptions, as production capacity for our products increases with our contract manufacturers, so will our ability to execute on timely delivery to meet the demand for our products in the U.S." Notes: About MustGrow MustGrow Biologics Corp. is a provider of innovative biological and regenerative agriculture solutions designed to support sustainable farming. The Company's technology is centered on harnessing the natural defense mechanisms and organic compounds found in mustard seed and formulating them into organic biofertility, biostimulant, and biocontrol products. These solutions are designed to protect soil health and the soil microbiome, support plant health, and contribute to global food security through more sustainable agricultural practices. In the United States, MustGrow's flagship biofertility product, TerraSante™, is registered, organ...

View stock analysis, news, and events for Mustgrow Biologics Corp.